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VESGEN Patents Pending 
Human Retina Mouse Retina
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Primary Risk   Spaceflight-Induced Intracranial Hypertension/Vision Alterations 
Primary Gap VIIP1   We do not know the etiological mechanisms and 
contributing risk factors 
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Hypothesis 
The retinal microvasculature withinnecessarily remodels 
during long-duration microgravityto accommodate ocular fluid shifts 
 
 
VESGEN 
Translational Mapping and Quantification 
 of Fractal-Based Vascular Branching Patterns 
From Physiological Rules 
 
Vascular Trees 
Retinal Vascular Disease, Mouse/Avian Coronary Vessels,  CAM, Yolksac 
 
Vascular Networks 
Mouse Intestinal Inflammation, CAM Lymphatic Vessels, Abnormal Mouse Corneal 
Angiogenesis, Drosophila (Fruitfly) Wing 
 
Vascular Tree-Network Composites 
Mouse Postnatal Retina, Early Embryonic Coronary Vessels, Juvenile and Adult Leaf Venation 
 
Mapping and Quantification by Multiparametric Weighted Analysis  
 
Fractal Dimension, Df 
Vessel Number Density, Nv 
Vessel Length Density, Lv 
Vessel Diameter, Dv 
Branchpoint + Endpoint Densities, Brv+Ev 
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VESGEN Patents Pending 
Human Retina Mouse Retina
WPanel to specify 
vessel type 
Main panel 
•  Image specification 
• Algorithm selection 
• Process initiation 
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VESGEN Patents Pending 
Mature, Beta-Level VESGEN 
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Common VESGEN Study Design for ISS Crew Members, 
70-Day HDT Bed Rest, and 90-Day HS Rodents 
 
 
•  Retrospective Human Subject Studies approved by NASA’s HHC, LSAH 
and IRB 
•  Phase 1    Masked VESGEN analysis of retinal images 
•  Phase 2    Unmasking of subject status and correlation with other ocular, 
vision and cardiovascular parameters 
•  Crew Members and Bed Rest   Retinal imaging by Heidelberg Spectralis 
30° Infrared (IR) 
•  8 Crew Members by 32 Spectralis IR images 
EARLY  Vascular  Nonproliferative DR (NPDR) 
                 LATE     Vascular  Proliferative DR (PDR)   
 
 
Diabetic Retinopathy 
 
Previous grading by secondary, indirect consequences, 
not primary, indirect vascular changes 
 
EARLY  Vascular  Nonproliferative DR (NPDR) 
LATE     Vascular  Proliferative DR (PDR)   
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Mapping
Mapping of Progressive Diabetic Retinopathy by VESGEN 
P Parsons-Wingerter, K Radhakrishnan, M B Vickerman, P K Kaiser, IOVS 51(1):498-507 (2010), in progress 
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Surprising, Innovative Paradigm Shift by VESGEN 
 
Alternation of Vascular Dropout with Vascular Growth 
(Angiogenesis) during Progression of Diabetic Retinopathy 
P Parsons-Wingerter, K Radhakrishnan, M B Vickerman, P K Kaiser, IOVS 51(1):498-507 (2010) and in progress 
New 
Regeneration 
Opportunity 
 Curr Eye Res 24(4):274 
Normal Retina 
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Surprising 
Results 
Grouping by Vascular Remodeling Status (VRS) 
P Parsons-Wingerter, K Radhakrishnan, M B Vickerman, P K Kaiser, IOVS 51(1):498-507 (2010), in progress 
P. Kaiser MD, Cole Eye Institute: P. Kaiser MD, Cole Eye Institute: P. Kaiser MD, Cole Eye Institute: 
                               with J Sears & Q Ebrahem (Cole Eye Institute), from Vickerman et al, Anatomical Record A 292(3), 2009     
 
Vascular Networks in Transgenic Mouse Retina 
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VESGEN Patents Pending 
34 
48 
179 
VESGEN Analysis/Patricia Parsons March 31, 2014 
Testing Vascular Systems Analysis for Longitudinal VllP Diagnosis Spectralis lmagestNitesh Patel March s, 2014 
VESGEN Maps of Arteries and Veins from High-Resolution Infrared (IR) Spectralis Imaging 
Arterial 
Lv (µm/µm2), N 1.58E-3, 93 
Lv (µmhtm2), N 1.56E-3, 88 
Lv (~tm/~tm2), N 1.81E-3, 130 
Grouped 2,4,8 Venous 
Small, Medium, Large 
1.30E-3, 90 
1.25E-3, 86 
1.66E-3, 138 
Grouped 2,4,8[7] 
Small, Medium, Large 
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VESGEN Patents Pending 
Differences in Spectralis IR Image Background 
between April 2014 Study and Current Crew Members, HDT 
 
 
 
 
 
 
 
 
 
 
Dr N Patel March 2014                                                              Crew Member 
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Preliminary Phase 1 VESGEN Results 
for Crew Members Pre- and Post-Flight to the ISS 
 
 
 
•  8 Crew Members by 32 Spectralis IR images 
 
•  Phase 1, Phase 2, Final Report complete by mid April 2017 
•  Phase 1    Masked VESGEN analysis of retinal images 
•  Phase 2    Unmasking of subject status and correlation with other ocular, 
vision and cardiovascular parameters 
•  Crew Members and Bed Rest   Retinal imaging by Heidelberg Spectralis 
30° Infrared (IR) 
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Comparison of VESGEN Analysis for Arterial and Venous Trees 
In the Retina of ISS Crew Member Pre- and Post-Flight to ISS 
 
 
 
VESGEN Example  Companion images of identical Crew Member retina 
 30° IR image resolution of vessels matched by vessel diameter 
VESGEN Patents Pending 
 
 
Conclusions 
 
 
 
 
•  Phase 1 nearing completion: VESGEN analysis of vascular patterning in 
the retinas of 8 Crew Members by 32 Spectralis IR images 
 
•  Phase 1, Phase 2, Final Report complete by mid April 2017 
 
•  VESGEN Results for Crew Members will be compared with 70-Day HDT 
Bed Rest study and 90-Day Rodent Hindlimb Suspension (in progress) 
•  Definitive testing of our hypothesis requires more advanced imaging of 
blood vessels in the retina and choroid by newer technologies such as 
OCT-A and AOSLO 
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with mild NPDR. moderate NPDR. severe NPDR or very 
obtamed by 50° fluorescein angiography (FA) Binary 
the FA's by semi-automatic image processing The 30 
1) Into successively smaller branching generations (G,-G 
branchpomt and endpoint densities (Br,+E 
sity. Results were grouped according to 
more accurately predictive of vascular 
bhshed, secondary vascular character 
less, VRS correlation with clinical d1 
remodeling. 
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